Unlocking the Future of Animal Health: Zomedica’s Innovative Technologies and Expert Insights
Zomedica Corp., a leading veterinary health company, has launched a new monthly webinar series designed to showcase its innovative product portfolio, introduce key personnel, and educate investors and strategic partners on the company’s long-term growth strategy. This exclusive series offers a unique opportunity for veterinarians, investors, and industry leaders to stay ahead of the curve in animal healthcare.
Game-Changing Technologies
Zomedica’s product portfolio features several groundbreaking technologies that are transforming the veterinary industry:
• **PulseVet Shock Wave System**: A revolutionary, non-invasive therapy that accelerates healing in musculoskeletal conditions, setting new standards in veterinary therapeutics. • **Assisi Loop and Calmer Canine Products**: Advanced tPEMF therapy devices that provide drug-free, highly effective pain and inflammation management, as well as the Calmer Canine therapy for behavioral separation anxiety. • **TRUFORMA Diagnostic Platform**: A next-generation in-clinic system offering unique, precise, rapid diagnostic testing to support complex veterinary cases with unparalleled accuracy at the point of care. • **TRUVIEW Digital Cytology System**: A best-in-class imaging and automation solution ensuring consistent quality, telepathology-backed confidence, and a streamlined workflow for faster, more accurate diagnoses in veterinary medicine. • **VETGuardian No-Touch Monitoring System**: A state-of-the-art, contact-free monitoring solution ensuring continuous remote tracking of vital signs for enhanced patient care. • **VETIGEL Hemostatic Gel**: An innovative, plant-based gel designed for rapid and effective bleeding control, revolutionizing wound management in veterinary medicine.
Expert Insights and Growth Opportunities
Zomedica’s webinar series will feature in-depth discussions with industry experts, Q&A opportunities with the leadership team, and product demonstrations. Investors and strategic partners will gain a deeper understanding of the company’s expanding market influence, robust R&D pipeline, and vision for sustainable revenue growth and shareholder value.
Benefits of Attending the Webinar Series
• **Stay Ahead of the Curve**: Attendees will gain first-hand insights into cutting-edge advancements in veterinary medicine and discover how Zomedica is driving innovation and expanding its market presence. • **Improve Patient Outcomes**: Learn about Zomedica’s groundbreaking technologies and strategies for improving animal health and well-being. • **Network with Industry Experts**: Connect with veterinarians, investors, and industry leaders to build relationships and stay informed about the latest developments in animal healthcare.
Registration and Details
Don’t miss this opportunity to connect with industry experts, discover groundbreaking technologies, and explore new possibilities in veterinary healthcare. The series is open to veterinary professionals, industry partners, investors, and all who are interested in improving the lives of our family pets. To secure your spot in the upcoming sessions, click on the link below or visit the company’s website. • **Webinar Registration**: https://us02web.zoom.us/webinar/register/WN_lUpmJTicRliHUCVyz6JEbg
• **Investor Relations**: investors@zomedica.com
• **Contact Information**: 1-734-369-2555
About Zomedica
Zomedica Corp. is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. With a suite of products that includes the PulseVet shock wave system, Assisi Loop and Calmer Canine products, TRUFORMA diagnostic platform, and TRUVIEW digital cytology system, Zomedica is revolutionizing veterinary medicine and improving the lives of pets worldwide.
Cautionary Note Regarding Forward-Looking Statements
Except for statements of historical fact, this news release contains certain “forward-looking information” or “forward-looking statements” (collectively, “forward-looking information”) within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate” and other similar words, or statements that certain events or conditions “may” or “will” occur and include statements relating to our expectations regarding future results. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance, or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information. The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information.
Conclusion
Zomedica’s innovative technologies and expert insights are revolutionizing the veterinary industry, and its webinar series offers a unique opportunity for veterinarians, investors, and industry leaders to stay ahead of the curve in animal healthcare. Don’t miss this chance to connect with industry experts, discover groundbreaking technologies, and explore new possibilities in veterinary healthcare. Register now and join the conversation!
